ArticleBone research2025
Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma.
Yujie Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleBone research2025
Yujie Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.